PM
56
2
MTB
75
2
COST
53
5
DHI
40
3
PSA
37
2
COP
44
-3
HOG
38
2
MAS
63
3
KO
44
2
IFF
62
5
CPB
37
2
AEE
58
3
MSI
47
-2
ES
50
3
ALLE
48
2
DVN
40
-2
PHM
43
2
AAPL
55
2
GIS
54
2
C
85
3
PM
56
2
MTB
75
2
COST
53
5
DHI
40
3
PSA
37
2
COP
44
-3
HOG
38
2
MAS
63
3
KO
44
2
IFF
62
5
CPB
37
2
AEE
58
3
MSI
47
-2
ES
50
3
ALLE
48
2
DVN
40
-2
PHM
43
2
AAPL
55
2
GIS
54
2
C
85
3
Financhill
Back

Vanguard Tax-Exempt Bond Index Fund ETF Vs. Travere Therapeutics, Inc. Industry Stock Comparison

Buy
55

VTEB
Vanguard Tax-Exempt Bond Index Fund ETF

Last Price:
$50.23
Seasonality Move:
-0.79%
Buy
80

TVTX
Travere Therapeutics, Inc.

Last Price:
$40.3200
Seasonality Move:
33.23%
Buy
55
Vanguard Tax-Exempt Bond Index Fund ETF (VTEB) is a Buy

Is Vanguard Tax-Exempt Bond Index Fund ETF a Buy, Sell or Hold?

  • The current Vanguard Tax-Exempt Bond Index Fund ETF [VTEB] share price is $50.23. The Score for VTEB is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
  • VTEB is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
80
Travere Therapeutics, Inc. (TVTX) is a Buy

Is Travere Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Travere Therapeutics, Inc. [TVTX] share price is $40.2800. The Score for TVTX is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
  • TVTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

VTEB Stock Price Chart

What is Vanguard Tax-Exempt Bond Index Fund ETF's stock price today?

  • The Vanguard Tax-Exempt Bond Index Fund ETF share price today is $50.23
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VTEB is experiencing slight buying pressure.

TVTX Stock Price Chart

What is Travere Therapeutics, Inc.'s stock price today?

  • The Travere Therapeutics, Inc. share price today is $40.2800
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TVTX is experiencing slight buying pressure.

VTEB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 12.39 Buy
Relative Strength Index (14 RSI): 47.36 Sell
Chaikin Money Flow: 1016616 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (50.18 - 50.4) Sell
Bollinger Bands (100): (49.33 - 50.53) Buy

TVTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 9.67 Buy
Relative Strength Index (14 RSI): 69.35 Buy
Chaikin Money Flow: 1508490 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (34.0318 - 36.4718) Buy
Bollinger Bands (100): (20.7309 - 34.2909) Buy

VTEB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 50.22 Buy
20-day SMA: 50.26 Sell
50-day SMA: 50.37 Sell
200-day SMA: 49.44 Buy
8-day EMA: 35.92 Buy
20-day EMA: 19.77 Buy
50-day EMA: 9.1 Buy
200-day EMA: 2.45 Buy

TVTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 35.7 Buy
20-day SMA: 35.23 Buy
50-day SMA: 33.43 Buy
200-day SMA: 22.2 Buy
8-day EMA: 28.52 Buy
20-day EMA: 16.32 Buy
50-day EMA: 7.67 Buy
200-day EMA: 2.09 Buy

Vanguard Tax-Exempt Bond Index Fund ETF Earnings Growth & VTEB Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Travere Therapeutics, Inc. Earnings Growth & TVTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.54 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.58 per share, and an increase next year of $1.08 per share.

Vanguard Tax-Exempt Bond Index Fund ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Travere Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):